Clinical relevance of the Maglumi immunoassay for anti-GAD65 in diabetes and neurological disorders: Analytical challenges and diagnostic insights​​on October 11, 2025 at 3:44 pm

Publication date: December 2025

Source: Clinical Biochemistry, Volume 140

Author(s): Gonzalo Verdú, Antonio Jesús Blanco-Carrasco, Raquel Ruiz-García, Albert Saiz, Manuel Morales-Ruiz, Gregori Casals

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

deneme bonusu veren siteler - canlı bahis siteleri - casino siteleri casino siteleri deneme bonusu veren siteler canlı casino siteleri error code: 523